Finance

Beta
Lists
3933:HKG
The United Laboratories Intl. Hldgs Ltd.
HK$8.80
+3.65%
(+0.31) 1D
May 29, 4:08:25 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3933...
Open
HK$8.54
High
HK$8.90
Low
HK$8.45
Mkt. cap
17.36B
Avg. vol.
6.17M
Volume
7.59M
Dividend
5.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Jul 7, 2026
P/E ratio
6.89
52-wk high
HK$17.98
52-wk low
HK$8.45
EPS
HK$1.28
Shares outstanding
1.64B
No. of employees
18K
Open
HK$8.54
High
HK$8.90
Low
HK$8.45
Mkt. cap
17.36B
Avg. vol.
6.17M
Volume
7.59M
Dividend
5.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Jul 7, 2026
P/E ratio
6.89
52-wk high
HK$17.98
52-wk low
HK$8.45
EPS
HK$1.28
Shares outstanding
1.64B
No. of employees
18K
News stories
From sources across the web
About The United Laboratories Intl. Hldgs Ltd.
CEO-
Employees18K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitetul.com.cn
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.76B
3.76B
2.85B
2.85B
Cost of goods sold
1.80B
1.80B
2.05B
2.05B
Cost of revenue
1.80B
1.80B
2.05B
2.05B
Research and development expenses
249.47M
249.47M
211.05M
211.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
558.68M
558.68M
592.61M
592.61M
Operating expense
837.14M
837.14M
809.10M
809.10M
Total operating expenses
2.63B
2.63B
2.86B
2.86B
Operating income
1.12B
1.12B
-14.00M
-14.00M
Other non operating income
32.08M
32.08M
67.65M
67.65M
EBT including unusual items
1.21B
1.21B
54.15M
54.15M
EBT excluding unusual items
1.20B
1.20B
40.86M
40.86M
Income tax expense
263.07M
263.07M
-39.64M
-39.64M
Effective tax rate
21.74%
21.74%
-73.20%
-73.20%
Other operating expenses
20.27M
20.27M
4.84M
4.84M
Net income
947.16M
947.16M
95.79M
95.79M
Net profit margin
25.19%
25.19%
3.37%
3.37%
Earnings per share
-
-
-
-
Interest and investment income
32.73M
32.73M
43.55M
43.55M
Interest expense
-10.40M
-10.40M
-24.47M
-24.47M
Net interest expenses
22.34M
22.34M
19.09M
19.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.28B
1.28B
141.00M
141.00M
Gain or loss from assets sale
-3.78M
-3.78M
-6.74M
-6.74M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more